Prognostic Value of MicroRNA-15a in Human Cancers: A Meta-Analysis and Bioinformatics

Table 2

Summary of HRs and their 95% CI.

Study	Year	Region	Disease	HR	OS	HR	DFS
					95% CI		95% CI
Utaijaratrasmi	2018	Thailand	ICC	3.452	1.188-10.030	NR	NR
Gopalan et al	2018	Australia	CRC	1.04	0.45-2.38	NR	NR
Fesler et al	2018	US	CRC	1.57	1.08-2.28	NR	NR
Shi et al	2017	China	OS	3.281	2.901-3.525	NR	NR
Kontos et al	2017	Greece	CRC	0.56	0.28-1.14	0.185	0.066-0.518
Li.J et al	2016	China	ESCC	3.668	1.193-8.283	3.808	1.032-7.838
Xie et al	2015	China	Glioma	7.52	2.63-21.47	11.56	5.17-25.96
Shinden et al	2015	Japan	BC	2.56	1.03-7.18	1.42	0.75-2.69
Li.F et al	2015	China	MM	3.57	1.08-12.50	NR	NR
Xiao et al	2014	China	CRC	3.016	1.129-6.616	2.782	1.122-6.031

DFS, disease-free survival; HR, hazard ratio; OS, overall survival.